Contact Us
Subscribe
E-Edition

56°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2025
Pet Contest

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Athira Pharma, Inc. - Common Stock (NQ:ATHA)

6.800 -0.770 (-10.17%)

Streaming Delayed Price Updated: 2:06 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Athira Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Athira Pharma Stock Shot Up 60% Today – What’s Triggering The Super Rally? ↗

December 18, 2025

Athira Pharma secured exclusive rights to a Phase 3 breast cancer drug and announced a $236 million financing package to support its development.

Via Stocktwits

Athira (ATHA) Q2 Loss Narrows 74% ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 05, 2025

Via Benzinga

Athira Outlines Possible Comeback For Alzheimer's Candidate ↗

September 06, 2022

Via Benzinga

Athira Pharma: Q2 Earnings Insights ↗

August 15, 2022

Athira Pharma (NASDAQ:ATHA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 01, 2024

Via Benzinga

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

November 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 31, 2024

Via Benzinga

Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 19, 2024

Via Benzinga

Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings ↗

September 04, 2024

Via Benzinga

US Stocks Mixed; Trade Gap Widens In July ↗

September 04, 2024

Via Benzinga

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks ↗

September 04, 2024

Athira Pharma stock falls as the company reports mixed results from its Phase 2/3 LIFT-AD clinical trial for Alzheimer's treatment fosgonimeton, with data showing directional improvements but no...

Via Benzinga

Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

September 04, 2024

Via Benzinga

ATHA Stock Earnings: Athira Pharma Beats EPS for Q2 2024 ↗

August 01, 2024

ATHA stock results show that Athira Pharma beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ATHA Stock Earnings: Athira Pharma Beats EPS for Q1 2024 ↗

May 15, 2024

ATHA stock results show that Athira Pharma beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 27, 2024

Via Benzinga

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

January 02, 2024

The Dow Jones index closed lower by around 20 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

How The Same Treatments May Work For Multiple Neurodegenerative Diseases ↗

September 21, 2023

Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate.

Via Talk Markets

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

Around $10M Bet On This Real Estate Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

June 07, 2023

The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

$1.7M Bet On Glatfelter? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

April 03, 2023

The Dow Jones closed higher by more than 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

4 Penny Stocks Insiders Are Buying: Athira Pharma, Great Elm Group And More ↗

January 03, 2023

US stocks recorded losses for 2022. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's...

Via Benzinga

Beachbody, Athira Pharma And This Penny Stock Insiders Are Aggressively Buying ↗

December 07, 2022

The Dow Jones closed lower by nearly 350 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Around $4 Million Bet On Lesaka Technologies? Check Out These 4 Penny Stocks Insiders Are Buying ↗

November 18, 2022

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗

July 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗

July 07, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Athira Pharma, Inc. - Common Stock (NQ:ATHA)

Headline News about Athira Pharma, Inc. - Common Stock

Sections

Services

Follow Us